The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 470.00
Bid: 450.00
Ask: 490.00
Change: 10.00 (2.17%)
Spread: 40.00 (8.889%)
Open: 460.00
High: 470.00
Low: 460.00
Prev. Close: 460.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

31 Aug 2022 07:00

RNS Number : 6661X
System1 Group PLC
31 August 2022
 

System1 Group PLC (AIM: SYS1)

("System1", or "the Company", or "the Group")

 

31 August 2022

 

Board Change

 

System1 Group plc (AIM: SYS1) announces that it has today appointed Conrad Bona to the Board of Directors of the Company as a Non-Executive Director effective from 1st September 2022.

 

Conrad is an investor, entrepreneur and consultant, who started his career as a banking and finance lawyer and has worked in Toronto, London and Tokyo. He has a degree in Economics from the University of Western Ontario, Law degrees from the University of Edinburgh and the University of New Brunswick and qualified to practise as a lawyer in multiple jurisdictions although he has not practised law in several years. Conrad is a partner in Wetherby Growth, an offshore fund which invests in pre-IPO companies. He also periodically advises companies on a wide range of commercial, financial and business matters. He has both Canadian and British citizenship. Conrad is also a Non-Executive Director of Grafenia plc.

 

John Kearon, Founder and Chief Executive Officer, commented: "I should like to welcome Conrad Bona to the Board and I am looking forward to working with him as we focus on delivering sustainable growth in the interests of all our stakeholders. His experience will further strengthen the Board's skillset and will contribute to our future success."

 

Details in respect of Conrad Bona, as required pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, are as set out below.

 

Additional Information

Conrad Christian Bona, age 53, is currently or has been a Director of the following companies within the past five years:

 

Current Directorships

Previous Directorships

Grafenia plc

Nil

Alphonse Resources Corp.

Paradise Global Cannabis Corp. 

CO2 Mitigation Limited

Wetherby Growth Limited

Wetherby Growth GP Limited

Wetherby Growth 2020 LP

Grayshott Limited

Invictus Investment Limited

 

There are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

John Kearon, Founder & CEO

Chris Willford, Chief Financial Officer

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts

 

The Company can be found at www.system1group.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAVBLFXLVLEBBE
Date   Source Headline
16th Apr 20247:00 amRNSTrading Update
24th Jan 20247:00 amRNSTrading Update
12th Dec 202312:51 pmRNSPresentation via Investor Meet Company
6th Dec 20237:00 amRNSChange of Auditor
6th Dec 20237:00 amRNSInterim Results
24th Oct 20237:00 amRNSTrading Update
27th Sep 20236:00 pmRNSResult of AGM
27th Sep 20237:00 amRNSTrading Update
31st Aug 20237:00 amRNSAnnual Report and Notice of AGM
1st Aug 20237:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2023
31st Jul 20232:00 pmRNSPreliminary Results Presentation
13th Jul 20237:30 amRNSTrading update
30th Jun 20239:00 amRNSResolution of Complaint for Trademark Infringement
28th Jun 202311:00 amRNSHolding(s) in Company
3rd May 20233:15 pmRNSFurther re Result of General Meeting
21st Apr 202311:56 amRNSResult of General Meeting
13th Apr 20237:00 amRNSFurther re Requisitioned General Meeting
12th Apr 20237:00 amRNSTrading Update
5th Apr 202310:45 amRNSNotice of Trading Update
24th Mar 20234:00 pmRNSPosting of Circular and Notice of Requisitioned GM
24th Mar 20237:00 amRNSPosting of Circular and Notice of Requisitioned GM
7th Mar 20237:30 amRNSReceipt of Requisition Notice
28th Feb 202312:50 pmRNSCapital Markets Day
23rd Feb 20237:00 amRNSTrading Update
14th Feb 20237:00 amRNSCapital Markets Day
13th Jan 20232:00 pmRNSDirector/PDMR Shareholding
10th Jan 202310:30 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 20224:00 pmRNSDirector/PDMR Shareholding
13th Dec 20226:25 pmRNSDirector/PDMR Shareholding
6th Dec 20224:15 pmRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Results
25th Oct 20227:00 amRNSTrading Update
28th Sep 20226:15 pmRNSResult of AGM
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
12th Jul 20227:00 amRNSQuarterly Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.